Oaktree Acquisition Corp. II (OACB) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free OACB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOaktree Seeks $2.5 Billion for Seventh Power Opportunities Fundbloomberg.com - April 18 at 6:00 PMDigital wealth platform Endowus partners with Brookfield Oaktree Wealth Solutionsmsn.com - December 5 at 10:34 PMEnphys Acquisition Corp Class A NFYSmorningstar.com - November 16 at 6:56 PMDuring the big storm 2 weeks ago we experienced many downed branches from a huge Oak tree at the front of our property.msn.com - October 2 at 2:21 PMOak Woods Acquisition Corp Ordinary Shares - Class Amorningstar.com - August 9 at 11:40 PMCORRECTED-UPDATE 2-Asset management firm Oaktree Capital set to appoint new co-CEOs - WSJmsn.com - June 28 at 8:40 AMEDTX - EdtechX Holdings Acquisition Corp. IIfinance.yahoo.com - June 27 at 8:38 AMOak Woods Acquisition Corp. Wtwsj.com - May 20 at 12:28 AMLIV Capital Acquisition Corp. II Cl Awsj.com - May 17 at 12:30 PMOaktree Specialty Lending Corporation (OCSL) Q2 2023 Earnings Call Transcriptseekingalpha.com - May 6 at 11:09 PMSchultze Special Purpose Acquisition Corp II Class A SAMA Stock Quotemorningstar.com - April 5 at 5:13 PM10-K: JAWS HURRICANE ACQUISITION CORPmarketwatch.com - April 2 at 9:20 AMEDTECHX HOLDINGS ACQUISTION CORP. II RECEIVES NASDAQ NOTIFICATION OF NON-COMPLIANCE WITH LISTING RULESbenzinga.com - March 12 at 10:00 PMLive Oak Mobility Acquisition Corp. Announces Redemption of Public Shares and Subsequent Dissolutionbenzinga.com - March 3 at 4:48 PMVCXA 10X Capital Venture Acquisition Corp. IIseekingalpha.com - February 23 at 3:44 PMOaktree Specialty Lending Corporation and Oaktree Strategic Income II, Inc. Announce Stockholder Approvals of Mergerbenzinga.com - January 20 at 5:09 PMOaktree Specialty Lending: Another Dividend Hike For This 10.3% Yielding BDCseekingalpha.com - November 24 at 11:39 AMAvista Public Acquisition Corp. II Cl Abarrons.com - October 30 at 9:40 PMAvista Public Acquisition Corp II (AHPA)investing.com - October 20 at 11:43 PMTREES RECEIVES LICENSE TO OPERATE IN BRITISH COLUMBIA, AND COMMENCES WITH CLOSING OF 5-STORE B.C. ASSET ACQUISITIONyahoo.com - September 4 at 8:50 AMAlvotech Reports First Half 2022 Financial Results and Business Updatetechnews.tmcnet.com - August 31 at 5:47 PMOaktree Specialty Lending Corporation Announces Third Fiscal Quarter 2022 Financial Results and Declares Increased Distribution of $0.17 Per Shareapnews.com - August 4 at 8:13 AMOlive Resource Capital Completes Acquisition of C$2.5M Portfolio of Assetsfinance.yahoo.com - August 3 at 12:34 AMOaktree Completes Acquisition of Majority Interest in 17Capitalapnews.com - July 19 at 12:22 PMAlvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combinationfinance.yahoo.com - June 7 at 4:21 PMOaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotechfinance.yahoo.com - June 3 at 8:22 PMShort Interest in Oaktree Acquisition Corp. II (NYSE:OACB) Increases By 3,196.7%marketbeat.com - May 25 at 1:34 PMAlvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®finance.yahoo.com - May 24 at 10:22 AMAlvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®finance.yahoo.com - May 16 at 9:14 AMOaktree Acquisition Corp. II (NYSE:OACB) Short Interest Updatemarketbeat.com - May 13 at 9:20 AMAlvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combinationfinance.yahoo.com - May 11 at 9:18 AMOACB_u Historical Datainvesting.com - May 4 at 8:49 PMAlvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbViefinance.yahoo.com - April 6 at 8:03 AMOaktree Acquisition Corp. II started at outperform at Northland ahead of Alvotech mergerseekingalpha.com - March 21 at 3:15 PMOaktree Acquisition Corp. II (NYSE:OACB) Earns Outperform Rating from Analysts at Northland Securitiesmarketbeat.com - March 21 at 9:06 AMAbbVie settles Humira lawsuit with Icelandic company Alvotechfinance.yahoo.com - March 9 at 3:31 PMAbbVie settles Humira patent dispute with Alvotechseekingalpha.com - March 9 at 10:31 AMAlvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®finance.yahoo.com - March 8 at 7:39 PMFDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®finance.yahoo.com - February 28 at 10:09 AMAlvotech Enters Exclusive Global Licensing Agreement with BiosanaPharma for Co-Development of a Proposed Biosimilar (AVT23) to Xolair® (Omalizumab)finance.yahoo.com - February 2 at 10:48 AMShould You Invest Your Hard Earned Cash in Oaktree Acquisition Corp. (OACB)?finance.yahoo.com - January 31 at 12:52 PMAlvotech Holdings S.A.: Alvotech Upsizes Oversubscribed PIPE Transaction to Approximately $175 Millionfinanznachrichten.de - January 20 at 7:59 PMAVT02, Alvotech’s Biosimilar to High Concentration Formulation of Adalimumab (Humira®) Approved for Use in European Unionapnews.com - December 15 at 6:41 PM3 SPACs Announce Mergers as DMYQ Set to Trade as Planet (PL) Tomorrowthestreet.com - December 7 at 7:13 PMSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Oaktree Acquisition Corp. II (NYSE - OACB)finance.yahoo.com - December 7 at 7:13 PMBiopharma company Alvotech to go public in $2.25 bln SPAC dealnasdaq.com - December 7 at 9:06 AMAlvotech And Oaktree Acquisition Corp. II Announce Merger Agreement; Combined Co. To Have Initial Enterprise Value Of ~$2.25Bbenzinga.com - December 7 at 9:06 AMUPDATE 2-Biopharma company Alvotech to go public in $2.25 bln SPAC dealfinance.yahoo.com - December 7 at 9:06 AM: SPAC Oaktree Acquisition Corp. II to take Iceland-based Alvotech public in a deal valuing combined co. at $2.25 blnmarketwatch.com - December 7 at 6:38 AMAlvotech to Go Public Through Oaktree SPAC Mergerfinance.yahoo.com - December 7 at 12:53 AM Get Oaktree Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for OACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. OACB Media Mentions By Week OACB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OACB News Sentiment▼0.000.42▲Average News Sentiment OACB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OACB Articles This Week▼00▲OACB Articles Average Week Get Oaktree Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for OACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OACB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
